Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Africa | 17 | 2021 | 2986 | 1.66 | Why? |
| International Cooperation | 7 | 2020 | 3436 | 1.33 | Why? |
| United States Agency for International Development | 1 | 2019 | 4 | 0.80 | Why? |
| Laboratory Personnel | 1 | 2021 | 126 | 0.77 | Why? |
| HIV Infections | 11 | 2021 | 11620 | 0.76 | Why? |
| Diagnostic Services | 1 | 2018 | 62 | 0.70 | Why? |
| Capacity Building | 2 | 2021 | 683 | 0.68 | Why? |
| Clinical Laboratory Services | 4 | 2021 | 781 | 0.66 | Why? |
| Public Health | 9 | 2021 | 16359 | 0.66 | Why? |
| Developed Countries | 1 | 2020 | 500 | 0.63 | Why? |
| Public Health Surveillance | 2 | 2021 | 3129 | 0.62 | Why? |
| Public-Private Sector Partnerships | 1 | 2019 | 259 | 0.60 | Why? |
| Goals | 1 | 2019 | 335 | 0.59 | Why? |
| Communicable Diseases | 2 | 2020 | 2148 | 0.58 | Why? |
| Laboratories | 4 | 2021 | 2858 | 0.58 | Why? |
| Security Measures | 1 | 2017 | 211 | 0.58 | Why? |
| Global Health | 10 | 2021 | 13911 | 0.54 | Why? |
| Health Priorities | 2 | 2021 | 959 | 0.53 | Why? |
| Dried Blood Spot Testing | 1 | 2017 | 383 | 0.52 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.47 | Why? |
| Hemorrhagic Fever, Ebola | 4 | 2021 | 1475 | 0.47 | Why? |
| Viral Load | 6 | 2019 | 15850 | 0.44 | Why? |
| HIV-1 | 4 | 2017 | 3365 | 0.43 | Why? |
| History, 20th Century | 4 | 2021 | 1282 | 0.42 | Why? |
| Disease Outbreaks | 5 | 2020 | 27595 | 0.42 | Why? |
| Africa South of the Sahara | 3 | 2021 | 1335 | 0.41 | Why? |
| Communicable Disease Control | 8 | 2021 | 29620 | 0.41 | Why? |
| Developing Countries | 3 | 2020 | 4283 | 0.40 | Why? |
| History, 21st Century | 4 | 2021 | 1849 | 0.39 | Why? |
| Anti-HIV Agents | 3 | 2020 | 2209 | 0.37 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3633 | 0.37 | Why? |
| Leadership | 2 | 2021 | 2241 | 0.37 | Why? |
| Drug Monitoring | 1 | 2017 | 1408 | 0.37 | Why? |
| Genomics | 1 | 2021 | 3118 | 0.37 | Why? |
| Income | 1 | 2018 | 1564 | 0.36 | Why? |
| Clinical Laboratory Techniques | 7 | 2020 | 23402 | 0.36 | Why? |
| Public Health Administration | 3 | 2021 | 846 | 0.34 | Why? |
| Communicable Diseases, Emerging | 2 | 2021 | 2523 | 0.34 | Why? |
| Epidemics | 3 | 2021 | 6407 | 0.31 | Why? |
| Kenya | 2 | 2021 | 887 | 0.31 | Why? |
| Poverty | 1 | 2018 | 2302 | 0.30 | Why? |
| Heteroduplex Analysis | 1 | 2003 | 3 | 0.27 | Why? |
| Genes, gag | 1 | 2003 | 5 | 0.27 | Why? |
| Acquired Immunodeficiency Syndrome | 2 | 2020 | 533 | 0.25 | Why? |
| Pandemics | 15 | 2021 | 389249 | 0.25 | Why? |
| CD4 Lymphocyte Count | 2 | 2018 | 1517 | 0.24 | Why? |
| Polymerase Chain Reaction | 1 | 2017 | 6740 | 0.23 | Why? |
| Healthcare Disparities | 1 | 2020 | 3893 | 0.23 | Why? |
| United Nations | 3 | 2019 | 367 | 0.22 | Why? |
| Early Diagnosis | 3 | 2019 | 2443 | 0.21 | Why? |
| Population Surveillance | 4 | 2021 | 4967 | 0.21 | Why? |
| Health Services Accessibility | 3 | 2021 | 10697 | 0.21 | Why? |
| Humans | 39 | 2021 | 930598 | 0.19 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.19 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.19 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.18 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.18 | Why? |
| Health Occupations | 1 | 2020 | 235 | 0.17 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.17 | Why? |
| Health Services Research | 2 | 2021 | 756 | 0.17 | Why? |
| Delivery of Health Care | 3 | 2021 | 15909 | 0.17 | Why? |
| Democratic Republic of the Congo | 1 | 2018 | 500 | 0.16 | Why? |
| Recombination, Genetic | 1 | 2003 | 1265 | 0.16 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.15 | Why? |
| Health Plan Implementation | 1 | 2020 | 571 | 0.14 | Why? |
| National Health Programs | 1 | 2021 | 807 | 0.13 | Why? |
| Efficiency, Organizational | 1 | 2017 | 482 | 0.13 | Why? |
| Health Planning | 1 | 2021 | 607 | 0.13 | Why? |
| Demography | 1 | 2020 | 1660 | 0.13 | Why? |
| Policy | 1 | 2021 | 1372 | 0.12 | Why? |
| Immunoenzyme Techniques | 1 | 2015 | 448 | 0.12 | Why? |
| Serologic Tests | 2 | 2019 | 4359 | 0.12 | Why? |
| HIV Seropositivity | 1 | 2015 | 320 | 0.12 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.12 | Why? |
| HIV | 1 | 2019 | 1116 | 0.11 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.11 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.11 | Why? |
| World Health Organization | 2 | 2020 | 4213 | 0.10 | Why? |
| Antibody Affinity | 1 | 2015 | 1078 | 0.10 | Why? |
| Cameroon | 2 | 2021 | 464 | 0.10 | Why? |
| Disease Management | 2 | 2017 | 6841 | 0.09 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.09 | Why? |
| Blood Donors | 1 | 2021 | 2956 | 0.08 | Why? |
| South Africa | 1 | 2017 | 3326 | 0.08 | Why? |
| Point-of-Care Systems | 2 | 2017 | 2955 | 0.08 | Why? |
| Forecasting | 1 | 2021 | 4492 | 0.08 | Why? |
| Politics | 1 | 2019 | 1824 | 0.07 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.07 | Why? |
| Point-of-Care Testing | 1 | 2018 | 2782 | 0.07 | Why? |
| Seroepidemiologic Studies | 1 | 2021 | 10017 | 0.07 | Why? |
| Influenza Vaccines | 1 | 2020 | 2941 | 0.07 | Why? |
| Cote d'Ivoire | 1 | 2003 | 115 | 0.07 | Why? |
| Databases, Factual | 1 | 2019 | 6248 | 0.06 | Why? |
| Biomedical Research | 2 | 2021 | 5270 | 0.06 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.06 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.06 | Why? |
| China | 2 | 2020 | 50654 | 0.06 | Why? |
| United States | 2 | 2020 | 46150 | 0.06 | Why? |
| Health Policy | 2 | 2021 | 6242 | 0.06 | Why? |
| Infant | 3 | 2019 | 30274 | 0.05 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.05 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.05 | Why? |
| Sensitivity and Specificity | 2 | 2018 | 22971 | 0.05 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.05 | Why? |
| Incidence | 1 | 2021 | 25622 | 0.05 | Why? |
| RNA, Viral | 2 | 2020 | 32276 | 0.04 | Why? |
| Cholera | 1 | 2021 | 189 | 0.04 | Why? |
| Yellow Fever | 1 | 2021 | 231 | 0.04 | Why? |
| Tanzania | 1 | 2018 | 294 | 0.04 | Why? |
| Chikungunya Fever | 1 | 2021 | 345 | 0.04 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.04 | Why? |
| Caribbean Region | 1 | 2017 | 349 | 0.04 | Why? |
| Malawi | 1 | 2017 | 287 | 0.04 | Why? |
| Information Dissemination | 2 | 2021 | 2986 | 0.03 | Why? |
| HIV Antigens | 1 | 2015 | 102 | 0.03 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.03 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.03 | Why? |
| Calibration | 1 | 2015 | 307 | 0.03 | Why? |
| Anxiety | 1 | 2020 | 17311 | 0.03 | Why? |
| Child | 2 | 2020 | 70012 | 0.03 | Why? |
| Hygiene | 1 | 2020 | 987 | 0.03 | Why? |
| DNA, Viral | 1 | 2003 | 2521 | 0.03 | Why? |
| Patient-Centered Care | 1 | 2021 | 860 | 0.03 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.03 | Why? |
| Animals | 1 | 2020 | 78931 | 0.03 | Why? |
| Genetic Variation | 1 | 2003 | 3919 | 0.02 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Cost-Benefit Analysis | 1 | 2017 | 2259 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Fear | 1 | 2021 | 3607 | 0.02 | Why? |
| Male | 4 | 2021 | 367725 | 0.02 | Why? |
| Virus Shedding | 1 | 2020 | 5834 | 0.02 | Why? |
| Female | 3 | 2021 | 380317 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.02 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.01 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Adult | 3 | 2021 | 244371 | 0.01 | Why? |
| Depression | 1 | 2021 | 14116 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2021 | 43792 | 0.01 | Why? |
| Adolescent | 1 | 2018 | 86841 | 0.01 | Why? |
| Aged | 1 | 2018 | 215776 | 0.00 | Why? |
| Middle Aged | 1 | 2018 | 270681 | 0.00 | Why? |
Nkengasong's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(144)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_